Insomnia Therapy - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509247669

Publication Date:

September 10, 2024

Pages:

131

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The global market for Insomnia Therapy was estimated to be worth US$ 2900 million in 2023 and is forecast to a readjusted size of US$ 4147.8 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insomnia Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Insomnia Therapy by region & country, by Type, and by Application.
The Insomnia Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapy.
麻豆原创 Segmentation
By Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type:
Non-pharmacological Therapy
Pharmacological Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insomnia Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Insomnia Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Insomnia Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Insomnia Therapy Product Introduction
1.2 Global Insomnia Therapy 麻豆原创 Size Forecast
1.3 Insomnia Therapy 麻豆原创 Trends & Drivers
1.3.1 Insomnia Therapy Industry Trends
1.3.2 Insomnia Therapy 麻豆原创 Drivers & Opportunity
1.3.3 Insomnia Therapy 麻豆原创 Challenges
1.3.4 Insomnia Therapy 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insomnia Therapy Players Revenue Ranking (2023)
2.2 Global Insomnia Therapy Revenue by Company (2019-2024)
2.3 Key Companies Insomnia Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Insomnia Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Insomnia Therapy
2.6 Insomnia Therapy 麻豆原创 Competitive Analysis
2.6.1 Insomnia Therapy 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Insomnia Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Non-pharmacological Therapy
3.1.2 Pharmacological Therapy
3.2 Global Insomnia Therapy Sales Value by Type
3.2.1 Global Insomnia Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insomnia Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Insomnia Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Insomnia Therapy Sales Value by Application
4.2.1 Global Insomnia Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insomnia Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Insomnia Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Insomnia Therapy Sales Value by Region
5.1.1 Global Insomnia Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insomnia Therapy Sales Value by Region (2019-2024)
5.1.3 Global Insomnia Therapy Sales Value by Region (2025-2030)
5.1.4 Global Insomnia Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Insomnia Therapy Sales Value, 2019-2030
5.2.2 North America Insomnia Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Insomnia Therapy Sales Value, 2019-2030
5.3.2 Europe Insomnia Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Insomnia Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Insomnia Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Insomnia Therapy Sales Value, 2019-2030
5.5.2 South America Insomnia Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Insomnia Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Insomnia Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insomnia Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insomnia Therapy Sales Value
6.3 United States
6.3.1 United States Insomnia Therapy Sales Value, 2019-2030
6.3.2 United States Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insomnia Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insomnia Therapy Sales Value, 2019-2030
6.4.2 Europe Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insomnia Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insomnia Therapy Sales Value, 2019-2030
6.5.2 China Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insomnia Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insomnia Therapy Sales Value, 2019-2030
6.6.2 Japan Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insomnia Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insomnia Therapy Sales Value, 2019-2030
6.7.2 South Korea Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insomnia Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insomnia Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insomnia Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insomnia Therapy Sales Value, 2019-2030
6.9.2 India Insomnia Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insomnia Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Profile
7.1.2 Merck & Co. Main Business
7.1.3 Merck & Co. Insomnia Therapy Products, Services and Solutions
7.1.4 Merck & Co. Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Merck & Co. Recent Developments
7.2 Sanofi
7.2.1 Sanofi Profile
7.2.2 Sanofi Main Business
7.2.3 Sanofi Insomnia Therapy Products, Services and Solutions
7.2.4 Sanofi Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Sanofi Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Insomnia Therapy Products, Services and Solutions
7.3.4 Pfizer Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Takeda Pharmaceutical Company Ltd. Recent Developments
7.4 Takeda Pharmaceutical Company Ltd.
7.4.1 Takeda Pharmaceutical Company Ltd. Profile
7.4.2 Takeda Pharmaceutical Company Ltd. Main Business
7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Products, Services and Solutions
7.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
7.5 Purdue Pharmaceuticals L.P.
7.5.1 Purdue Pharmaceuticals L.P. Profile
7.5.2 Purdue Pharmaceuticals L.P. Main Business
7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Products, Services and Solutions
7.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Purdue Pharmaceuticals L.P. Recent Developments
7.6 Eisai, Co. Ltd.
7.6.1 Eisai, Co. Ltd. Profile
7.6.2 Eisai, Co. Ltd. Main Business
7.6.3 Eisai, Co. Ltd. Insomnia Therapy Products, Services and Solutions
7.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Eisai, Co. Ltd. Recent Developments
7.7 Meda Consumer Healthcare
7.7.1 Meda Consumer Healthcare Profile
7.7.2 Meda Consumer Healthcare Main Business
7.7.3 Meda Consumer Healthcare Insomnia Therapy Products, Services and Solutions
7.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Meda Consumer Healthcare Recent Developments
7.8 Pernix Therapeutics
7.8.1 Pernix Therapeutics Profile
7.8.2 Pernix Therapeutics Main Business
7.8.3 Pernix Therapeutics Insomnia Therapy Products, Services and Solutions
7.8.4 Pernix Therapeutics Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Pernix Therapeutics Recent Developments
7.9 Vanda Pharmaceuticals
7.9.1 Vanda Pharmaceuticals Profile
7.9.2 Vanda Pharmaceuticals Main Business
7.9.3 Vanda Pharmaceuticals Insomnia Therapy Products, Services and Solutions
7.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Vanda Pharmaceuticals Recent Developments
7.10 ECR Pharmaceuticals
7.10.1 ECR Pharmaceuticals Profile
7.10.2 ECR Pharmaceuticals Main Business
7.10.3 ECR Pharmaceuticals Insomnia Therapy Products, Services and Solutions
7.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 ECR Pharmaceuticals Recent Developments
7.11 Fidia Farmaceutici
7.11.1 Fidia Farmaceutici Profile
7.11.2 Fidia Farmaceutici Main Business
7.11.3 Fidia Farmaceutici Insomnia Therapy Products, Services and Solutions
7.11.4 Fidia Farmaceutici Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Fidia Farmaceutici Recent Developments
7.12 Dainippon Sumitomo
7.12.1 Dainippon Sumitomo Profile
7.12.2 Dainippon Sumitomo Main Business
7.12.3 Dainippon Sumitomo Insomnia Therapy Products, Services and Solutions
7.12.4 Dainippon Sumitomo Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 Dainippon Sumitomo Recent Developments
7.13 Biocodex
7.13.1 Biocodex Profile
7.13.2 Biocodex Main Business
7.13.3 Biocodex Insomnia Therapy Products, Services and Solutions
7.13.4 Biocodex Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 Biocodex Recent Developments
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Profile
7.14.2 Eli Lilly and Company Main Business
7.14.3 Eli Lilly and Company Insomnia Therapy Products, Services and Solutions
7.14.4 Eli Lilly and Company Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.14.5 Eli Lilly and Company Recent Developments
7.15 Ebb Therapeutics
7.15.1 Ebb Therapeutics Profile
7.15.2 Ebb Therapeutics Main Business
7.15.3 Ebb Therapeutics Insomnia Therapy Products, Services and Solutions
7.15.4 Ebb Therapeutics Insomnia Therapy Revenue (US$ Million) & (2019-2024)
7.15.5 Ebb Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Insomnia Therapy Industrial Chain
8.2 Insomnia Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insomnia Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Insomnia Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.